Brief: Zevra Therapeutics Files Preliminary Proxy
31/03/2025 23:40
March 31 (Reuters) - Zevra Therapeutics Inc ZVRA.O: ZEVRA THERAPEUTICS FILES PRELIMINARY PROXY ZEVRA THERAPEUTICS: CONFIRMS RECEIPT OF TWO DIRECTOR NOMINEES FROM DANIEL J. MANGLESS Source text: ID:nGNX8DTHDL Further company coverage: ZVRA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zevra Therapeutics
See all newsZevra Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Zevra Therapeutics Q2 revenue rises 53% on MIPLYFFA sales
Zevra Therapeutics Inc expected to post earnings of 11 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Tenet, SLB, Digital Realty
U.S. STOCKS ON THE MOVE-Booz Allen Hamilton, Sensient, Amkor